Clinical Trial: Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

Clinical Trial: Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

Sponsor and Collaborators
University of Miami Sylvester Comprehensive Cancer Center

Principal Investigator
Edgardo Santos, MD, University of Miami Sylvester Comprehensive Cancer Center

ClinicalTrials.gov Identifier
NCT01209520